title: [Management of brain metastases from non-small cell lung carcinoma].
abstract: BACKGROUND
  In France, approximately 30,000 new patients per year develop brain metastases (BM), most of them resulting from a lung cancer.
  
  
  BACKGROUND
  Surgery and radiosurgery of all the BM must be considered when possible. In other cases, whole brain radiotherapy remains the standard of care.
  
  
  CONCLUSIONS
  The role of chemotherapy, poorly investigated so far, should be revisited.
  
  
  CONCLUSIONS
  This review focused on BM secondary to a non-small cell lung carcinoma.
authors.affiliation: Service de neurologie, hôpital Avicenne, AP-HP, 125, route de Stalingrad, 93000 Bobigny, France.
authors.forename: O
authors.initials: O
authors.lastname: Bailon
authors.forename: A
authors.initials: A
authors.lastname: Kallel
authors.forename: K
authors.initials: K
authors.lastname: Chouahnia
authors.forename: S
authors.initials: S
authors.lastname: Billot
authors.forename: D
authors.initials: D
authors.lastname: Ferrari
authors.forename: A-F
authors.initials: AF
authors.lastname: Carpentier
mesh_terms: D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery / Q000628:therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000145:classification / Q000473:pathology*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000145:classification / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D016032:Randomized Controlled Trials as Topic